The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR).
 
Giacomo Giulio Baldi
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar
 
Bruno Vincenzi
No Relationships to Disclose
 
Tommaso Martino De Pas
No Relationships to Disclose
 
Maria A. Pantaleo
No Relationships to Disclose
 
Lorenzo D'Ambrosio
No Relationships to Disclose
 
Giovanni Grignani
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Michela Casanova
Consulting or Advisory Role - Bayer; Halozyme; Lilly; Merck; Roche; SERVIER; Tesaro
 
Andrea Ferrari
No Relationships to Disclose
 
Noemi Simeone
No Relationships to Disclose
 
Salvatore Provenzano
No Relationships to Disclose
 
Angelo Paolo Dei Tos
No Relationships to Disclose
 
Marta Sbaraglia
No Relationships to Disclose
 
Paola Collini
No Relationships to Disclose
 
Gianpaolo Dagrada
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - ARIAD/Merck; Bayer; Blueprint Medicines; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar